You are here

funding

Nuvig pulls in $161M to make better immune drugs

BioPharma Dive

Thu, 12/5/24 - 11:11 am

Maze Therapeutics Raises $115M in Series D Financing

FinSMEs

Tue, 12/3/24 - 11:31 am

Maze Therapeutics

Novo Holdings-backed Adcendo secures $135M for ADC pipeline

Fierce Biotech

Mon, 11/25/24 - 11:10 am

antibody-drug conjugate

Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1

BioSpace

Wed, 11/13/24 - 11:20 am

TRex Bio raises $84M to compete in crowded immune drug field

BioPharma Dive

Wed, 11/13/24 - 10:51 am

Disc Medicine secures $200m financing to support trials

Clinical Trials Arena

Mon, 11/11/24 - 11:30 am

clinical trials

Neurogene secures $200M ahead of anticipated study readout

BioPharma Dive

Mon, 11/4/24 - 06:55 pm

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies

PR Newswire

Wed, 10/30/24 - 11:52 am

Blue Earth Therapeutics

A new biotech, built around protein design, springs from David Baker’s lab

BioPharma Dive

Wed, 10/30/24 - 11:45 am

Archon Biosciences

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Pharmaceutical Technology

Fri, 10/25/24 - 11:08 am

fibrotic disease

As new Alzheimer’s biomarkers come into play, here’s where the money is going

Pharma Voice

Thu, 10/17/24 - 09:20 am

Alzheimer's disease

KdT Ventures Announces Oversubscribed Fund IV to Invest in Early-Stage Frontier Science Companies

Businesswire

Wed, 10/16/24 - 05:24 pm

Forbion follows string of startup exits with $2.2B fundraise

BioPharma Dive

Wed, 10/16/24 - 12:27 pm

Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration

Fierce Biotech

Thu, 10/10/24 - 11:21 am

Booster Therapeutics

targeted protein degradation

Startup led by John Maraganore raises $135M to build ‘future of RNAi’

BioPharma Dive

Tue, 10/8/24 - 09:50 pm

City Therapeutics

John Maraganore

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

BioPharma Dive

Mon, 10/7/24 - 11:18 am

Triveni Bio's $115M haul ramps up push for precision I&I therapies

First Word Pharma

Wed, 10/2/24 - 09:43 am

Kailera launches with $400M series A and clutch of Chinese obesity drugs

Fierce Biotech

Tue, 10/1/24 - 09:57 am

Kailera Therapuetics

Cerevel Therapeutics

Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B

Fierce Biotech

Mon, 09/30/24 - 09:40 am

radiopharmaceuticals

Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science

BioPharma Dive

Thu, 09/26/24 - 11:15 am

Arch Venture Partners

Pages